查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1710114

2025年全球癌症活體組織切片市場報告

Cancer Biopsy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年癌症活體組織切片市場規模將快速成長。到 2029 年，這一數字將成長至 472 億美元，年複合成長率（CAGR）為 13.4%。預測期內的成長是由於患者數量的增加、老年人口的增加、疑似患有乳癌的患者數量的增加、癌症病例數量的增加、診斷和切片檢查測試數量的增加以及患者數量的增加。預測期內的主要趨勢包括技術進步、人工智慧和機器學習、多體學整合、產品創新和照護現場切片檢查。

預計癌症發病率的上升將推動癌症活體組織切片市場的成長。癌症的特徵是異常細胞的生長和擴散，由於生活方式改變、都市化、環境污染、菸草和酒精消費以及醫療保健機會和意識的差異等因素，癌症變得越來越普遍。切片檢查透過從可疑區域取出並分析組織或細胞，對於診斷和評估癌症的類型、階段和進展至關重要。例如，美國國家生物技術資訊中心報告稱，2023年1月，美國新增癌症病例1,958,310例，癌症相關死亡病例609,820例。此外，根據美國國家醫學圖書館2021年5月發布的報告，預計到2040年全球癌症患者數將達到2,840萬人，比2020年增加47%，死亡率也將隨之上升。盛行率的不斷上升是推動切片檢查需求的關鍵因素。

癌症活體組織切片市場的主要企業正在推進液態切片技術，以實現癌症的非侵入性早期檢測和監測，從而改善患者的治療效果並支持更個人化的治療方法。液態切片是一種先進的診斷方法，可以分析血液樣本中的遺傳物質，包括循環腫瘤 DNA (ctDNA)、RNA、外泌體和其他生物標記。 Labcorp 是美國癌症活體組織切片解決方案的領導者，於 2023 年 5 月推出了 Labcorp Plasma Focus，這是一種基於血漿的液態切片，旨在檢測癌症相關的生物標記。等離子聚焦測試分析血液中癌細胞的循環遊離 DNA（cfDNA），以創建患者腫瘤的基因組圖譜，並識別與一系列癌症相關的 33 個基因的突變，包括非小細胞肺癌、結直腸癌、乳癌、食道癌和黑色素瘤。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球癌症活體組織切片PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球癌症活體組織切片市場：成長率分析
  • 全球癌症活體組織切片市場表現：規模與成長，2019-2024
  • 全球癌症活體組織切片市場預測：2024-2029 年及 2034 年規模與成長
  • 全球癌症活體組織切片總目標市場（TAM）

第6章市場區隔

  • 全球癌症活體組織切片市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 組織切片檢查
  • 液態生物檢體
  • 其他類型
  • 全球癌症活體組織切片市場：按應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 乳癌
  • 大腸直腸癌
  • 子宮頸癌
  • 肺癌
  • 攝護腺癌
  • 皮膚癌
  • 血癌
  • 腎癌
  • 其他用途
  • 全球癌症活體組織切片市場：按最終用戶、業績和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診斷實驗室
  • 其他最終用戶
  • 全球癌症活體組織切片市場依組織切片檢查類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 芯針切片
  • 細針抽吸（FNA）切片檢查
  • 切口切片檢查
  • 切除切片檢查
  • 全球癌症活體組織切片市場，依液態生物檢體類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 循環性腫瘤細胞（CTC）分析
  • 循環腫瘤DNA（ctDNA）檢測
  • 血漿生物標記檢測
  • 全球癌症活體組織切片市場，按類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 骨切片檢查
  • 內視鏡切片檢查
  • 刷切片檢查
  • 皮膚切片檢查

第7章 區域和國家分析

  • 全球癌症活體組織切片市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球癌症活體組織切片市場：按國家/地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 癌症活體組織切片市場：競爭格局
  • 癌症活體組織切片市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Exact Sciences Corporation
  • Myriad Genetics Inc.
  • Guardant Health Inc.
  • Veracyte Inc.
  • GRAIL Inc.
  • Freenome Holdings Inc.
  • Biodesix Inc.
  • Chronix Biomedical Inc.
  • Biocept Inc.
  • Personal Genome Diagnostics Inc.
  • Agena Bioscience Inc.
  • Oncimmune Holdings plc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年癌症活體組織切片市場：提供新機會的國家
  • 2029 年癌症活體組織切片市場：細分領域帶來新機會
  • 2029年癌症活體組織切片市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r31693

A cancer biopsy is a medical procedure in which a small sample of tissue or cells is extracted from a suspicious area of the body to determine the presence of cancer or other conditions. This procedure is essential for diagnosing cancer, as imaging tests such as CT scans or MRIs cannot definitively differentiate between cancerous and non-cancerous cells.

The primary types of cancer biopsies include tissue biopsies, liquid biopsies, and others. Tissue biopsies involve extracting a small tissue sample from the body for microscopic examination. These procedures are used to diagnose various types of cancer, including breast, colorectal, cervical, lung, prostate, skin, blood, kidney, and other cancers. They are employed by different end users, such as hospitals, diagnostic laboratories, and other healthcare facilities.

The cancer biopsy market research report is one of a series of new reports from The Business Research Company that provides cancer biopsy market statistics, including cancer biopsy industry global market size, regional shares, competitors with a cancer biopsy market share, detailed cancer biopsy market segments, market trends, and opportunities, and any further data you may need to thrive in the cancer biopsy industry. This cancer biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer biopsy market size has grown rapidly in recent years. It will grow from $25.08 $ billion in 2024 to $28.52 $ billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to increasing awareness of breast cancer liquid biopsy procedures, rising awareness of inherited oncology disorders and genetic testing, increasing adoption of liquid biopsies, increasing demand of for minimally invasive biopsy treatments, increasing demand for tissue biopsies.

The cancer biopsy market size is expected to see rapid growth in the next few years. It will grow to $47.2 $ billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to an increase in the number of patients, the growing elderly population, the growing number of patients suspected of having breast cancer, the rise in cancer cases, an increase in the diagnosis and biopsies testing, increase in the number of patients. Major trends in the forecast period include technological advancements, artificial intelligence and machine learning, integration of multi-omics, product innovations, and point-of-care biopsy devices.

The increasing incidence of cancer is expected to drive growth in the cancer biopsy market. Cancer, characterized by abnormal cell growth and spread, is becoming more prevalent due to factors such as lifestyle changes, urbanization, environmental pollution, tobacco and alcohol consumption, and disparities in healthcare access and awareness. Cancer biopsies are crucial for diagnosing and assessing cancer type, stage, and progression by extracting and analyzing tissue or cells from suspicious areas. For instance, the National Center for Biotechnology Information reported in January 2023 that the United States had 1,958,310 new cancer cases and 609,820 cancer-related deaths. Additionally, a May 2021 report from the National Library of Medicine forecasted a global cancer burden of 28.4 million cases by 2040, representing a 47% increase from 2020, along with a corresponding rise in mortality rates. This growing prevalence is a significant factor driving the demand for cancer biopsies.

Key players in the cancer biopsy market are advancing liquid biopsy technologies to enable non-invasive, early detection and monitoring of cancer, thereby improving patient outcomes and supporting more personalized treatment approaches. Liquid biopsy is an advanced diagnostic method that analyzes genetic material in blood samples, including circulating tumor DNA (ctDNA), RNA, exosomes, and other biomarkers. In May 2023, Labcorp, a US-based leader in cancer biopsy solutions, launched Labcorp Plasma Focus, a plasma-based liquid biopsy designed to detect cancer-related biomarkers. The Plasma Focus test analyzes circulating cell-free DNA (cfDNA) from tumor cells in the bloodstream to generate a genomic profile of the patient's tumor, identifying mutations across 33 genes associated with various cancers, including non-small cell lung cancer, colorectal cancer, breast cancer, esophageal cancer, and melanoma.

In June 2023, Quest Diagnostics, a US-based provider of diagnostic information services, acquired Haystack Oncology for up to $450 million. This acquisition aims to enhance Quest Diagnostics' expertise in cancer diagnostics, particularly in the detection of minimal residual disease (MRD). Haystack Oncology is a US-based company that specializes in liquid biopsy technology for cancer detection.

Major companies operating in the cancer biopsy market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Roche Diagnostics GmbH, Hologic Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., Guardant Health Inc., Veracyte Inc., GRAIL Inc., Freenome Holdings Inc., Biodesix Inc., Chronix Biomedical Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Oncimmune Holdings plc, Exosome Diagnostics Inc., Epigenomics AG, Genesystems Inc., Lucence Diagnostics Pte. Ltd., ANGLE plc

North America was the largest region in the cancer biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer biopsy market consists of sales of biopsy needles, biopsy guns, and biopsy punches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Tissue Biopsies; Liquid Biopsies; Other Types
  • 2) By Application: Breast Cancer; Colorectal Cancer; Cervical Cancers; Lung Cancers; Prostate Cancers; Skin Cancers; Blood Cancers; Kidney Cancers; Other Applications
  • 3) By End User: Hospitals; Diagnostic Laboratories; Other End Users
  • Subsegments:
  • 1) By Tissue Biopsies: Core Needle Biopsies; Fine Needle Aspiration (FNA) Biopsies; Incisional Biopsies; Excisional Biopsies
  • 2) By Liquid Biopsies: Circulating Tumor Cell (CTC) Analysis; Circulating Tumor DNA (ctDNA) Testing; Plasma Biomarker Testing
  • 3) By Other Types: Bone Biopsies; Endoscopic Biopsies; Brush Biopsies; Skin Biopsies
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Becton Dickinson and Company; Roche Diagnostics GmbH; Hologic Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cancer Biopsy Market Characteristics

3. Cancer Biopsy Market Trends And Strategies

4. Cancer Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cancer Biopsy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cancer Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cancer Biopsy Market Growth Rate Analysis
  • 5.4. Global Cancer Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cancer Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cancer Biopsy Total Addressable Market (TAM)

6. Cancer Biopsy Market Segmentation

  • 6.1. Global Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue Biopsies
  • Liquid Biopsies
  • Other Types
  • 6.2. Global Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancers
  • Lung Cancers
  • Prostate Cancers
  • Skin Cancers
  • Blood Cancers
  • Kidney Cancers
  • Other Applications
  • 6.3. Global Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Other End Users
  • 6.4. Global Cancer Biopsy Market, Sub-Segmentation Of Tissue Biopsies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Core Needle Biopsies
  • Fine Needle Aspiration (FNA) Biopsies
  • Incisional Biopsies
  • Excisional Biopsies
  • 6.5. Global Cancer Biopsy Market, Sub-Segmentation Of Liquid Biopsies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Circulating Tumor Cell (CTC) Analysis
  • Circulating Tumor DNA (ctDNA) Testing
  • Plasma Biomarker Testing
  • 6.6. Global Cancer Biopsy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone Biopsies
  • Endoscopic Biopsies
  • Brush Biopsies
  • Skin Biopsies

7. Cancer Biopsy Market Regional And Country Analysis

  • 7.1. Global Cancer Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cancer Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Biopsy Market

  • 8.1. Asia-Pacific Cancer Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Biopsy Market

  • 9.1. China Cancer Biopsy Market Overview
  • 9.2. China Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Biopsy Market

  • 10.1. India Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Biopsy Market

  • 11.1. Japan Cancer Biopsy Market Overview
  • 11.2. Japan Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Biopsy Market

  • 12.1. Australia Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Biopsy Market

  • 13.1. Indonesia Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Biopsy Market

  • 14.1. South Korea Cancer Biopsy Market Overview
  • 14.2. South Korea Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Biopsy Market

  • 15.1. Western Europe Cancer Biopsy Market Overview
  • 15.2. Western Europe Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Biopsy Market

  • 16.1. UK Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Biopsy Market

  • 17.1. Germany Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Biopsy Market

  • 18.1. France Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Biopsy Market

  • 19.1. Italy Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Biopsy Market

  • 20.1. Spain Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Biopsy Market

  • 21.1. Eastern Europe Cancer Biopsy Market Overview
  • 21.2. Eastern Europe Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Biopsy Market

  • 22.1. Russia Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Biopsy Market

  • 23.1. North America Cancer Biopsy Market Overview
  • 23.2. North America Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Biopsy Market

  • 24.1. USA Cancer Biopsy Market Overview
  • 24.2. USA Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Biopsy Market

  • 25.1. Canada Cancer Biopsy Market Overview
  • 25.2. Canada Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Biopsy Market

  • 26.1. South America Cancer Biopsy Market Overview
  • 26.2. South America Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Biopsy Market

  • 27.1. Brazil Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Biopsy Market

  • 28.1. Middle East Cancer Biopsy Market Overview
  • 28.2. Middle East Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Biopsy Market

  • 29.1. Africa Cancer Biopsy Market Overview
  • 29.2. Africa Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Biopsy Market Competitive Landscape And Company Profiles

  • 30.1. Cancer Biopsy Market Competitive Landscape
  • 30.2. Cancer Biopsy Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Biopsy Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. QIAGEN N.V.
  • 31.4. Exact Sciences Corporation
  • 31.5. Myriad Genetics Inc.
  • 31.6. Guardant Health Inc.
  • 31.7. Veracyte Inc.
  • 31.8. GRAIL Inc.
  • 31.9. Freenome Holdings Inc.
  • 31.10. Biodesix Inc.
  • 31.11. Chronix Biomedical Inc.
  • 31.12. Biocept Inc.
  • 31.13. Personal Genome Diagnostics Inc.
  • 31.14. Agena Bioscience Inc.
  • 31.15. Oncimmune Holdings plc

32. Global Cancer Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Biopsy Market

34. Recent Developments In The Cancer Biopsy Market

35. Cancer Biopsy Market High Potential Countries, Segments and Strategies

  • 35.1 Cancer Biopsy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cancer Biopsy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cancer Biopsy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer